![]() |
|
|
Vol. 27, Issue 11, 1248-1253, November 1999
School of Pharmacy, Tokyo University of Pharmacy and Life Science,
Tokyo, Japan
Antipyrine is a useful probe to evaluate variation of in vivo
activities of oxidative hepatic drug-metabolizing enzymes. Here we
describe a new approach using 13C labeling and NMR
spectroscopy for the direct and simultaneous detection of all phase I
and phase II metabolites of antipyrine in rat urine.
[C-methyl-13C]Antipyrine was synthesized
and administered orally to rats (100 mg/kg), and the 0- to 24-h
postdose urine was analyzed by 100-MHz 13C NMR spectroscopy
under the conditions of distortionless enhancement by polarization
transfer without any pretreatments such as deconjugation, chromatographic separation, and solvent extraction. Consequently, all
the major metabolites in urine were successfully detected with
favorable signal-to-noise ratios in the limited acquisition time (30 min). The assignments of the resonances were performed by
enzymic modification and spiking authentic samples. The
reproducibility of the NMR detection was sufficient for the
quantitative evaluation of the metabolic profile. Effects of
3-methylcholanthrene on antipyrine metabolism were examined by this
approach to evaluate variation of in vivo phase I and phase II
metabolism of antipyrine in rats. The present approach is useful and
practical to evaluate variation of in vivo activities of conjugation
enzymes as well as oxidation enzymes responsible for the formation of
antipyrine metabolites in rats. This direct approach would enhance the
value of the antipyrine test because of the simplicity and convenience.
This article has been cited by other articles:
![]() |
K. Akira, E. Negishi, M. Imachi, and T. Hashimoto Direct Nuclear Magnetic Resonance Spectroscopic Analysis of 13C-Labeled Antipyrine Metabolites in Human Urine Drug Metab. Dispos., June 1, 2001; 29(6): 903 - 907. [Abstract] [Full Text] |
||||